DPI-386 Nasal Gel, Other (e.g., promethazine, meclizine) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-tra
Phase 2 · Motion Sickness, Space, Motion Simulation |
Repurposed Therapeutics, Inc. | DPI-386 Nasal Gel, Other (e.g., prometha |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|